0.11
Impact Factor
0.09
5-Years IF
6
5-Years H index
CitEc is a RePEc service
providing citation data for Economics since 2001
providing citation data for Economics since 2001
Last updated December, 3 2015 760.408 documents
processed, 20.499.313 references and 8.066.571 citations
[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ]
[more data in EconPapers] [
trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
| IF | AIF | IF5 | DOC | CDO | CCU | CIF | CIT | D2Y | C2Y | D5Y | C5Y | %SC | CiY | II | AII | |
| 1990 | 0.09 | 0 | 0 | 0 | (%) | 0.03 | ||||||||||
| 1991 | 0.09 | 0 | 0 | 0 | (%) | 0.04 | ||||||||||
| 1992 | 0.09 | 0 | 0 | 0 | (%) | 0.04 | ||||||||||
| 1993 | 0.1 | 0 | 0 | 0 | (%) | 0.05 | ||||||||||
| 1994 | 0.11 | 0 | 0 | 0 | (%) | 0.05 | ||||||||||
| 1995 | 0.19 | 0 | 0 | 0 | (%) | 0.07 | ||||||||||
| 1996 | 0.23 | 0 | 0 | 0 | (%) | 0.09 | ||||||||||
| 1997 | 0.27 | 10 | 10 | 3 | 0 | 0 | (%) | 0.09 | ||||||||
| 1998 | 0.27 | 12 | 22 | 1 | 10 | 10 | (%) | 0.1 | ||||||||
| 1999 | 0.31 | 22 | 4 | 0.18 | 22 | 22 | (%) | 0.13 | ||||||||
| 2000 | 0.39 | 0.05 | 9 | 31 | 1 | 0.03 | 1 | 12 | 22 | 1 | 1 (100%) | 0.15 | ||||
| 2001 | 0.41 | 3 | 34 | 9 | 31 | (%) | 0.16 | |||||||||
| 2002 | 0.43 | 34 | 12 | 34 | (%) | 0.19 | ||||||||||
| 2003 | 0.45 | 5 | 39 | 3 | 24 | (%) | 0.19 | |||||||||
| 2004 | 0.51 | 1 | 40 | 5 | 17 | (%) | 0.21 | |||||||||
| 2005 | 0.54 | 7 | 47 | 1 | 0.02 | 2 | 6 | 18 | (%) | 0.22 | ||||||
| 2006 | 0.52 | 62 | 109 | 1 | 0.01 | 19 | 8 | 16 | 1 (5.3%) | 0.21 | ||||||
| 2007 | 0.03 | 0.45 | 0.03 | 38 | 147 | 3 | 0.02 | 6 | 69 | 2 | 75 | 2 | (%) | 0.18 | ||
| 2008 | 0.48 | 22 | 169 | 21 | 100 | 113 | (%) | 0.2 | ||||||||
| 2009 | 0.48 | 28 | 197 | 3 | 60 | 130 | (%) | 0.19 | ||||||||
| 2010 | 0.02 | 0.44 | 0.02 | 33 | 230 | 4 | 0.02 | 8 | 50 | 1 | 157 | 3 | 1 (12.5%) | 0.16 | ||
| 2011 | 0.02 | 0.53 | 0.02 | 32 | 262 | 4 | 0.02 | 17 | 61 | 1 | 183 | 4 | 3 (17.6%) | 0.21 | ||
| 2012 | 0.05 | 0.58 | 0.04 | 87 | 349 | 12 | 0.03 | 11 | 65 | 3 | 153 | 6 | 4 (36.4%) | 1 | 0.01 | 0.22 |
| 2013 | 0.04 | 0.71 | 0.05 | 96 | 445 | 25 | 0.06 | 43 | 119 | 5 | 202 | 10 | 29 (67.4%) | 7 | 0.07 | 0.25 |
| 2014 | 0.11 | 0.81 | 0.09 | 123 | 568 | 70 | 0.12 | 37 | 183 | 21 | 276 | 26 | 10 (27%) | 19 | 0.15 | 0.28 |
| IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y IF5: Impact Factor: C5Y / D5Y DOC: Number of documents published in year y CDO: Cumulative number of documents published until year y CCU: Cumulative number of citations to papers published until year y CIF: Cumulative impact factor CIT: Number of citations to papers published in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 D5Y: Number of articles published in y-1 until y-5 C5Y: Cites in y to articles published in y-1 until y-5 %SC: Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y II: Immediacy Index: CiY / Documents. AII: Average Immediacy Index for series in RePEc in year y |
|
50 most cited documents in this series:
[Click on heading to sort table]
| Year | Title | Cited |
|---|---|---|
| 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Husereau, Don ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers || Download paper | 26 |
| 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 15 |
| 2014 | Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69. Full description at Econpapers || Download paper | 10 |
| Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Ghislandi, Simone ; Galizzi, Matteo . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 10 | |
| 2014 | Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43. Full description at Econpapers || Download paper | 7 |
| 2014 | Japanâs monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24. Full description at Econpapers || Download paper | 7 |
| 2014 | Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79. Full description at Econpapers || Download paper | 6 |
| 2006 | Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996â2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902. Full description at Econpapers || Download paper | 5 |
| 2006 | The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25. Full description at Econpapers || Download paper | 5 |
| Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Benedict, Agnes ; Muszbek, Noemi ; Kreif, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675. Full description at Econpapers || Download paper | 4 | |
| 1997 | Guidelines for Pharmacoeconomic Studies. (1997). Luce, Bryan ; Weinstein, Milton ; Gold, Marthe ; Russell, Louise ; Siegel, Joanna ; Torrance, George . In: PharmacoEconomics. RePEc:spr:pharme:v:11:y:1997:i:2:p:159-168. Full description at Econpapers || Download paper | 3 |
| 2011 | Do Productivity Costs Matter?. (2011). Papenburg, Joce ; Brouwer, Werner ; Krol, Marieke ; Koopmanschap, Marc . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619. Full description at Econpapers || Download paper | 3 |
| 2012 | Common Drug Review Recommendations. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert ; Miller, Elizabeth . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:229-246. Full description at Econpapers || Download paper | 3 |
| 2007 | Direct and Indirect Costs Attributable to Alcohol Consumption in Germany. (2007). Konnopka, Alexander ; Konig, Hans-Helmut . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:7:p:605-618. Full description at Econpapers || Download paper | 2 |
| 2006 | Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf ; Wille, Nora ; Bullinger, Monika ; Erhart, Michael . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220. Full description at Econpapers || Download paper | 2 |
| 2014 | Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room. (2014). Pekarsky, Brita ; Eckermann, Simon . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:319-325. Full description at Econpapers || Download paper | 2 |
| 2010 | An Analysis of NICEâs âRestrictedâ (or âOptimizedâ) Decisions. (2010). Devlin, Nancy ; ONeill, Phill . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:11:p:987-993. Full description at Econpapers || Download paper | 2 |
| 2006 | The Impact of Therapeutic Reference Pricing on Innovation in Cardiovascular Medicine. (2006). SHERIDAN, DESMOND ; ATTRIDGE, JIM. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:35-54. Full description at Econpapers || Download paper | 2 |
| 2005 | Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. (2005). Briggs, Andrew ; Grossman, Ronald ; Spencer, Michael ; Rance, Laureen . In: PharmacoEconomics. RePEc:spr:pharme:v:23:y:2005:i:6:p:619-637. Full description at Econpapers || Download paper | 2 |
| 2012 | Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001â7. (2012). Lichtenberg, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211. Full description at Econpapers || Download paper | 2 |
| 2011 | Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV. (2011). Figueroa-Lara, Alejandro ; Yared Santa-Ana-Tellez, ; Wirtz, Veronika ; Galarraga, Omar ; Viisainen, Kirsi ; Coulibaly, Ibrahima ; Korenromp, Eline ; Medina-Lara, Antonieta . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:579-599. Full description at Econpapers || Download paper | 2 |
| 2013 | The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies. (2013). McGrath, Clare ; Camejo, Rodrigo Refoios ; Miraldo, Marisa ; Rutten, Frans . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:445-454. Full description at Econpapers || Download paper | 2 |
| 2010 | International Comparison of Comparative Effectiveness Research in Five Jurisdictions. (2010). Levy, Adrian ; Johnston, Karissa ; Mitton, Craig ; Harrigan, Brian ; Briggs, Andrew . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:10:p:813-830. Full description at Econpapers || Download paper | 2 |
| 2013 | Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797. Full description at Econpapers || Download paper | 2 |
| 2008 | Assessing the Impact of Global Price Interdependencies. (2008). Richter, Anke . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:649-659. Full description at Econpapers || Download paper | 2 |
| 2013 | How to Include Informal Care in Economic Evaluations. (2013). Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers || Download paper | 2 |
| 2008 | Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616. Full description at Econpapers || Download paper | 1 |
| 2013 | Decision-Makersâ Preferences for Approving New Medicines in Wales: A Discrete-Choice Experiment with Assessment of External Validity. (2013). Hughes, Dyfrig ; Linley, Warren . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:4:p:345-355. Full description at Econpapers || Download paper | 1 |
| 2015 | The Economic Burden of Obesity by Glycemic Stage in the United States. (2015). Li, Qian ; Graf, Thomas ; Hammer, Mette ; Huang, Joanna ; Blume, Steven . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:735-748. Full description at Econpapers || Download paper | 1 |
| 2010 | Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?. (2010). Salkeld, Glenn ; Kelly, Patrick ; Stockler, Martin ; Chim, Lesley . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:6:p:463-475. Full description at Econpapers || Download paper | 1 |
| 2014 | A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). Epstein, David ; Faria, Rita ; Gomes, Manuel ; White, Ian . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers || Download paper | 1 |
| 2014 | Cross-border comparative studies of service quality and consumer satisfaction: some empirical results. (2014). Wu, Ming-Lu . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:89-106. Full description at Econpapers || Download paper | 1 |
| 2006 | The Impact of Incremental Innovation in Biopharmaceuticals. (2006). Berndt, Ernst ; Grepin, Karen ; Cockburn, Iain . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:2:p:69-86. Full description at Econpapers || Download paper | 1 |
| 2012 | The Burden of Moderate to Severe Psoriasis. (2012). Koleva, Daniela Mihajlova ; Naldi, Luigi ; Garattini, Livio ; Raho, Giovanna . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:1005-1013. Full description at Econpapers || Download paper | 1 |
| 2014 | Health-Related Productivity Loss: NICE to Recognize Soon, Good to Discuss Now. (2014). Anis, Aslam ; Zhang, Wei . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:5:p:425-427. Full description at Econpapers || Download paper | 1 |
| 2013 | Eliciting Preferences for Prioritizing Treatment of Rare Diseases: the Role of Opportunity Costs and Framing Effects. (2013). Desser, Arna ; Grepperud, Sverre ; Olsen, Jan . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:11:p:1051-1061. Full description at Econpapers || Download paper | 1 |
| 2015 | Exploring Structural Uncertainty in Model-Based Economic Evaluations. (2015). Karnon, Jonathan ; Hossein Haji Ali Afzali, . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:435-443. Full description at Econpapers || Download paper | 1 |
| 2009 | Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster. (2009). Rusinak, Donna ; Lieu, Tracy ; Kleinman, Ken ; Ortega-Sanchez, Ismael ; Ray, G.. In: PharmacoEconomics. RePEc:spr:pharme:v:27:y:2009:i:12:p:1005-1016. Full description at Econpapers || Download paper | 1 |
| 2011 | Does the Market Share of Generic Medicines Influence the Price Level?. (2011). Dylst, Pieter ; Simoens, Steven . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:10:p:875-882. Full description at Econpapers || Download paper | 1 |
| 2007 | Economic Evidence at the Local Level. (2007). Gallego, Gisselle ; Viney, Rosalie ; Ward, Robyn ; Haas, Marion ; Gool, Kees ; Hall, Jane . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:12:p:1055-1062. Full description at Econpapers || Download paper | 1 |
| 2012 | Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:219-227. Full description at Econpapers || Download paper | 1 |
| 2014 | NICEâs Cost-Effectiveness Range: Should it be Lowered?. (2014). Raftery, J.. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:7:p:613-615. Full description at Econpapers || Download paper | 1 |
| 2008 | Future Drug Prices and Cost-Effectiveness Analyses. (2008). Hoyle, Martin . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:589-602. Full description at Econpapers || Download paper | 1 |
| 2013 | Korean Guidelines for Pharmacoeconomic Evaluation (Second and Updated Version). (2013). Bae, Eun ; Jang, Sunmee ; Lee, SooOk . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:4:p:257-267. Full description at Econpapers || Download paper | 1 |
| 2015 | Do Statins Reduce the Health and Health Care Costs of Obesity?. (2015). Gaudette, etienne ; Sood, Neeraj ; Messali, Andrew ; Goldman, Dana . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:723-734. Full description at Econpapers || Download paper | 1 |
| 2014 | Some Inconsistencies in NICEâs Consideration of Social Values. (2014). McCabe, Christopher ; Paulden, Mike ; OMahony, James . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1043-1053. Full description at Econpapers || Download paper | 1 |
| 2014 | Treatment Sequencing After Failure of the First Biologic in Cost-Effectiveness Models of Psoriasis: A Systematic Review of Published Models and Clinical Practice Guidelines. (2014). McBride, Doreen ; Mallya, Usha ; Feldman, Steven ; Samuel, Miny ; Mauskopf, Josephine . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:395-409. Full description at Econpapers || Download paper | 1 |
| 2007 | Cost Effectiveness of an Adherence-Improving Programme in Hypertensive Patients. (2007). Dirksen, Carmen ; Leeuw, Peter ; Nelemans, Patricia ; Prins, Martin ; Joore, Manuela ; Severens, Johan ; Schouten, Jan ; Stoffers, Henri ; Wetzels, Gwenn ; Brunenberg, Danielle . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:3:p:239-251. Full description at Econpapers || Download paper | 1 |
| 2013 | Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients. (2013). Blazquez-Perez, Antonio ; San Miguel, Ramon ; Mar, Javier . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:10:p:919-931. Full description at Econpapers || Download paper | 1 |
| 2015 | A Primer on Marginal EffectsâPart I: Theory and Formulae. (2015). Onukwugha, Eberechukwu ; Jain, Rahul ; Bergtold, Jason . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:1:p:25-30. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series:
Papers most cited in the last two years. [Click on heading to sort table]
| Year | Title | Cited |
|---|---|---|
| 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Husereau, Don ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers || Download paper | 21 |
| 2008 | Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers || Download paper | 13 |
| 2014 | Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69. Full description at Econpapers || Download paper | 10 |
| 2011 | Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Ghislandi, Simone ; Galizzi, Matteo . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers || Download paper | 9 |
| 2014 | Japanâs monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24. Full description at Econpapers || Download paper | 7 |
| 2014 | Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43. Full description at Econpapers || Download paper | 7 |
| 2014 | Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79. Full description at Econpapers || Download paper | 6 |
| 2006 | Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996â2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902. Full description at Econpapers || Download paper | 4 |
| 2006 | The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25. Full description at Econpapers || Download paper | 4 |
| 2012 | Common Drug Review Recommendations. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert ; Miller, Elizabeth . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:229-246. Full description at Econpapers || Download paper | 3 |
| 2013 | Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Benedict, Agnes ; Muszbek, Noemi ; Kreif, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675. Full description at Econpapers || Download paper | 3 |
| 2006 | Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf ; Wille, Nora ; Bullinger, Monika ; Erhart, Michael . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220. Full description at Econpapers || Download paper | 2 |
| 2008 | Assessing the Impact of Global Price Interdependencies. (2008). Richter, Anke . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:649-659. Full description at Econpapers || Download paper | 2 |
| 2013 | The Determinants of Cost-Effectiveness Potential: An Historical Perspective on Lipid-Lowering Therapies. (2013). McGrath, Clare ; Camejo, Rodrigo Refoios ; Miraldo, Marisa ; Rutten, Frans . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:445-454. Full description at Econpapers || Download paper | 2 |
| 2014 | Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room. (2014). Pekarsky, Brita ; Eckermann, Simon . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:319-325. Full description at Econpapers || Download paper | 2 |
| 2011 | Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV. (2011). Figueroa-Lara, Alejandro ; Yared Santa-Ana-Tellez, ; Wirtz, Veronika ; Galarraga, Omar ; Viisainen, Kirsi ; Coulibaly, Ibrahima ; Korenromp, Eline ; Medina-Lara, Antonieta . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:579-599. Full description at Econpapers || Download paper | 2 |
| 2011 | Do Productivity Costs Matter?. (2011). Papenburg, Joce ; Brouwer, Werner ; Krol, Marieke ; Koopmanschap, Marc . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619. Full description at Econpapers || Download paper | 2 |
| 2012 | Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001â7. (2012). Lichtenberg, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211. Full description at Econpapers || Download paper | 2 |
| 2005 | Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. (2005). Briggs, Andrew ; Grossman, Ronald ; Spencer, Michael ; Rance, Laureen . In: PharmacoEconomics. RePEc:spr:pharme:v:23:y:2005:i:6:p:619-637. Full description at Econpapers || Download paper | 2 |
| 2013 | How to Include Informal Care in Economic Evaluations. (2013). Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers || Download paper | 2 |
| 2010 | International Comparison of Comparative Effectiveness Research in Five Jurisdictions. (2010). Levy, Adrian ; Johnston, Karissa ; Mitton, Craig ; Harrigan, Brian ; Briggs, Andrew . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:10:p:813-830. Full description at Econpapers || Download paper | 2 |
| 2013 | Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797. Full description at Econpapers || Download paper | 2 |
Citing documents used to compute impact factor 21:
[Click on heading to sort table]
| Year | Title | See |
|---|---|---|
| 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Krol, Marieke ; Brouwer, Werner . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease. (2014). Severens, Johan ; Redekop, William ; Burgers, Laura . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:7:p:627-637. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Economic Evaluations of Gastroesophageal Reflux Disease Medical Management. (2014). Gawron, Andrew ; Pandolfino, John ; French, Dustin ; Howden, Colin . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:8:p:745-758. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Cost Effectiveness of a Pharmacist-Led Information Technology Intervention for Reducing Rates of Clinically Important Errors in Medicines Management in General Practices (PINCER). (2014). Avery, Anthony ; Rodgers, Sarah ; Elliott, Rachel ; Verhaeghe, Nick ; Franklin, Matthew ; Eden, Martin ; ANNEMANS, Lieven ; Putman, Koen ; Hayre, Jasdeep ; Sheikh, Aziz . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:573-590. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Cost and Cost Effectiveness of Vaginal Progesterone Gel in Reducing Preterm Birth: An Economic Analysis of the PREGNANT Trial. (2014). Jutkowitz, Eric ; Berghella, Vincenzo ; Seligman, Neil ; Pizzi, Laura ; Baxter, Jason . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:5:p:467-478. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Decision-Analytic Models: Current Methodological Challenges. (2014). Caro, J. ; Moller, Jorgen . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:943-950. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder. (2014). Mohiuddin, Syed . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:12:y:2014:i:4:p:359-372. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models. (2014). Chilcott, James ; Tappenden, Paul . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:967-979. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review. (2014). Schultz, Neil ; Lee, Todd ; Zueger, Patrick . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1079-1091. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | A Review of the Methodological Challenges in Assessing the Cost Effectiveness of Pharmacist Interventions. (2014). Davies, James ; Elliott, Rachel ; ANNEMANS, Lieven ; Putman, Koen . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1185-1199. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. (2014). Stollenwerk, Bjorn ; Leidl, Reiner ; Yates, Nichola ; Hatz, Maximilian . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:377-393. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Lymphocytic Leukaemia: A Review of Methods to Model Disease Outcomes and Estimate Utility. (2014). Griebsch, Ingolf ; Xu, Peng ; Orfanos, Panagiotis ; Marsh, Kevin ; Gordon, James. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:981-993. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Life at a premium: considering an end-of-life premium in Value Based Reimbursement.. (2014). Culyer, Anthony ; Edlin, Richard ; Paulden, Mike ; O'Mahony, James ; McCabe, Christopher . In: Working Papers. RePEc:lee:wpaper:1407. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Distribution of health-related social surplus in pharmaceuticals: an estimation of consumer and producer surplus in the management of high blood lipids and COPD. (2014). McGrath, Clare ; Camejo, Rodrigo ; Miraldo, Marisa ; Rutten, Frans . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:4:p:439-445. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries. (2014). Rencz, Fanni ; Brodszky, Valentin ; Lopert, Ruth ; Baji, Petra ; Hever, Noemi ; Pentek, Marta ; Gulacsi, Laszlo . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:1:p:27-34. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres. (2014). Szegedi, Andrea ; Brodszky, Valentin ; Karpati, Sarolta ; Baji, Petra ; Hollo, Peter ; Balogh, Orsolya ; Gulacsi, Laszlo ; Herszenyi, Krisztina ; Jokai, Hajnalka ; Remenyik, eva ; Heredi, Emese . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:1:p:101-109. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Mapping EQ-5D Utility Scores from the PedsQL⢠Generic Core Scales. (2014). Khan, Kamran ; Walters, Stephen ; Petrou, Stavros ; Boyle, Spencer ; Rivero-Arias, Oliver . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:7:p:693-706. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999â2010. (2014). Lichtenberg, Frank R. ; alkan, Zafer ; Tatar, Mehtap . In: Health Policy. RePEc:eee:hepoli:v:117:y:2014:i:3:p:361-373. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making. (2014). Fernandez, Jose-Luis ; Knapp, Martin ; Cerri, Karin . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:7:p:681-695. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Analysing coverage decision-making: opening Pandoraâs box?. (2014). Fischer, Katharina . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:15:y:2014:i:9:p:899-906. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | How to Estimate Productivity Costs in Economic Evaluations. (2014). Krol, Marieke ; Brouwer, Werner . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers || Download paper | [Citation Analysis] |
Recent citations received in: 2014
[Click on heading to sort table]
| Year | Title | See |
|---|---|---|
| 2014 | Addressing elimination and selection by aspects decision rules in discrete choice experiments: does it matter?. (2014). Thompson, Carl ; Campbell, Danny . In: 2014 Annual Meeting, July 27-29, 2014, Minneapolis, Minnesota. RePEc:ags:aaea14:169839. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Global Entrepreneurship Monitor The Netherlands 2013. (2014). van Stel, Andre ; Span, Tommy ; Hessels, Jolanda . In: Scales Research Reports. RePEc:eim:papers:h201407. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | The Willingness to Pay for a QALY: a Review of the Empirical
Literature. (2014). Ryen, Linda . In: Karlstad University Working Papers in Economics. RePEc:hhs:kaunek:0012. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Editorial Volume 7(3). (2014). Schofield, Deborah J ; Shrestha, Rupendra ; Carter, Hannah E. In: International Journal of Microsimulation. RePEc:ijm:journl:v:7:y:2014:i:3:p:33-52. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Life at a premium: considering an end-of-life premium in Value Based Reimbursement.. (2014). Culyer, Anthony ; Edlin, Richard ; Paulden, Mike ; O'Mahony, James ; McCabe, Christopher . In: Working Papers. RePEc:lee:wpaper:1407. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:25-43. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Japanâs monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:3-24. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Kilinc, Mustafa ; Fendoglu, Salih . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:45-69. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Ermisoglu, Ergun . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:1:p:71-79. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Hedging with mini gold futures: evidence from Korea. (2014). Park, Cheolho ; Yun, Youngjun ; Kim, Seokchin . In: Eurasian Economic Review. RePEc:spr:eurase:v:4:y:2014:i:2:p:163-176. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Is health care expenditure across Europe converging? Findings from the application of a nonlinear panel unit root test. (2014). Lau, Chi ; Pugalis, Lee ; Fung, Ka. In: Eurasian Business Review. RePEc:spr:eurasi:v:4:y:2014:i:2:p:137-156. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Patterns of innovation and wage distribution. Do âinnovative firmsâ pay higher wages? Evidence from Chile. (2014). Cirillo, Valeria . In: Eurasian Business Review. RePEc:spr:eurasi:v:4:y:2014:i:2:p:181-206. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Does Diabetes Have an Impact on Health-State Utility? A Study of Asians in Singapore. (2014). Tai, E. ; Wang, P. ; Luo, Nan ; Thumboo, J. ; Vrijhoef, Hubertus . In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:7:y:2014:i:3:p:329-337. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Modelling Technique, Structural Assumptions, Input Parameter Values: Which Has the Most Impact on the Results of a Cost-Effectiveness Analysis?. (2014). Mauskopf, Josephine . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:521-523. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation. (2014). Hagen, Gunhild ; Wisloff, Torbjorn ; Klemp, Marianne . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:6:p:601-612. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Japanâs monetary policy in a challenging environment. (2014). Shirai, Sayuri . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2014 | Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79. Full description at Econpapers || Download paper | [Citation Analysis] |
Recent citations received in: 2013
[Click on heading to sort table]
| Year | Title | See |
|---|---|---|
| 2013 | Personalised medicine as a challenge for public pricing and reimbursement authorities â A survey among 27 European countries on the example of trastuzumab. (2013). Mantel-Teeuwisse, A. K. ; Vogler, S. ; Espin, J. ; Leopold, C. ; Habl, C.. In: Health Policy. RePEc:eee:hepoli:v:113:y:2013:i:3:p:313-322. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2013 | Leasing health technologies- an affordable and effective reimbursement strategy for innovative
technologies?. (2013). McCabe, Christopher ; Edlin, Richard ; Hall, Peter ; Wallner, Klemens . In: Working Papers. RePEc:lee:wpaper:1302. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2013 | Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from Eortic QLQ Data in Myeloma for Use in Cost effectiveness Analysis. (2013). Browne, Chantelle ; Kharroubi, Samer A ; Edlin, Richard ; Meads, David ; McCabe, Christopher . In: Working Papers. RePEc:lee:wpaper:1308. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2013 | Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. (2013). Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Husereau, Don ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:14:y:2013:i:3:p:367-372. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2013 | Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the US. (2013). Hellinger, Fred . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1091-1104. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2013 | How Much Should the NHS Pay for a QALY?. (2013). Haycox, Alan . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:357-359. Full description at Econpapers || Download paper | [Citation Analysis] |
| 2013 | Good Practice Guidelines for the use of Statistical Regression Models in Economic Evaluations. (2013). Wailoo, Allan ; Ara, Roberta ; Alava, Monica ; Campbell, Mike ; Abrams, Keith ; Kearns, Ben ; Manca, Andrea . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:643-652. Full description at Econpapers || Download paper | [Citation Analysis] |
Recent citations received in: 2012
[Click on heading to sort table]
| Year | Title | See |
|---|---|---|
| 2012 | The Authorsâ Reply. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:980-980. Full description at Econpapers || Download paper | [Citation Analysis] |
10 most frequent citing series:
[Click on heading to sort table]
Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.
Source data used to compute the impact factor of RePEc series.